Global Cord Blood (NYSE:CO) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO) in a report released on Monday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Stock Down 16.7 %

Shares of CO stock opened at $1.05 on Monday. The company’s fifty day simple moving average is $1.40 and its 200-day simple moving average is $1.40. The firm has a market cap of $127.63 million, a PE ratio of 1.64 and a beta of 0.16. Global Cord Blood has a 12 month low of $2.03 and a 12 month high of $5.50.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.